MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma

Haoran Lu,1,* Rou Zhao,2,* Qianqian Qin,3 Liyong Tang,1 Guodong Ma,1 Baoyu He,2 Jing Liang,2 Li Wei,2 Xutong Wang,2 Qingli Bie,2 Xuning Wang,4 Bin Zhang2,5 1Department of Hepatobiliary Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shand...

Full description

Bibliographic Details
Main Authors: Lu H, Zhao R, Qin Q, Tang L, Ma G, He B, Liang J, Wei L, Wang X, Bie Q, Zhang B
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:International Journal of General Medicine
Subjects:
myristoylated alanine-rich c-kinase substrate
hcc
tcga
prognostic value
Online Access:https://www.dovepress.com/marcks-is-a-new-prognostic-biomarker-in-hepatocellular-carcinoma-peer-reviewed-fulltext-article-IJGM

Internet

https://www.dovepress.com/marcks-is-a-new-prognostic-biomarker-in-hepatocellular-carcinoma-peer-reviewed-fulltext-article-IJGM

Similar Items